BR9407306A - Pharmaceutical composition for oral administration and process for preparing the same - Google Patents

Pharmaceutical composition for oral administration and process for preparing the same

Info

Publication number
BR9407306A
BR9407306A BR9407306A BR9407306A BR9407306A BR 9407306 A BR9407306 A BR 9407306A BR 9407306 A BR9407306 A BR 9407306A BR 9407306 A BR9407306 A BR 9407306A BR 9407306 A BR9407306 A BR 9407306A
Authority
BR
Brazil
Prior art keywords
preparing
same
pharmaceutical composition
oral administration
oral
Prior art date
Application number
BR9407306A
Other languages
Portuguese (pt)
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9407306A publication Critical patent/BR9407306A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
BR9407306A 1993-08-20 1994-08-19 Pharmaceutical composition for oral administration and process for preparing the same BR9407306A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (en) 1993-08-20 1993-08-20 PHARMACEUTICAL FORMULA CONTAINING A HORMON
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Publications (1)

Publication Number Publication Date
BR9407306A true BR9407306A (en) 1996-10-08

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9407306A BR9407306A (en) 1993-08-20 1994-08-19 Pharmaceutical composition for oral administration and process for preparing the same

Country Status (17)

Country Link
EP (1) EP0789560A1 (en)
JP (1) JPH09501682A (en)
KR (1) KR960703570A (en)
CN (1) CN1132478A (en)
AU (1) AU7530594A (en)
BR (1) BR9407306A (en)
CA (1) CA2169840A1 (en)
CZ (1) CZ42596A3 (en)
DK (1) DK95093D0 (en)
FI (1) FI960749A0 (en)
HU (1) HUT74167A (en)
LT (1) LT4043B (en)
NO (1) NO960653D0 (en)
NZ (1) NZ271617A (en)
PL (1) PL313113A1 (en)
SK (1) SK19396A3 (en)
WO (1) WO1995005807A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (en) * 1997-12-19 2001-03-09 Besins Iscovesco Lab PROGESTERONE TABLET AND PROCESS FOR THE PREPARATION THEREOF
FR2775599B1 (en) 1998-03-09 2001-08-17 Besins Iscovesco Lab PHARMACEUTICAL COMPOSITION BASED ON SYNTHESIS NATURAL PROGESTERONE AND OESTRADIOL AND PROCESS FOR PREPARING THE SAME
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
KR101019361B1 (en) * 1999-08-31 2011-03-07 바이엘 쉐링 파마 악티엔게젤샤프트 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768A (en) * 2000-12-18 2002-06-19 Licentia Oy Entero-coated pharmaceutical compositions and their preparation
EP1482946A1 (en) * 2002-03-14 2004-12-08 Watson Pharmaceuticals, Inc. Progesterone oral drug delivery system
ES2312996T3 (en) * 2003-04-29 2009-03-01 N.V. Organon SOLIDIFICATION PROCESS WITH ANTIDISOLVENT.
AU2006287925B2 (en) 2005-04-28 2012-03-01 Wyeth Compositions containing micronized tanaproget
AT12800U1 (en) * 2007-11-05 2012-11-15 Bayer Schering Pharma Ag A pharmaceutical preparation for use in the oral contraception of lactose intolerant women
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (en) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3310359A4 (en) 2015-06-22 2019-04-03 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (en) 1976-11-30 1979-06-08 Besins Jean Louis NEW COMPOSITION WITH ANTI-CONCEPTIONAL ACTION
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
AU5157590A (en) * 1989-02-06 1990-08-24 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
FI960749A (en) 1996-02-19
NZ271617A (en) 1996-11-26
WO1995005807A1 (en) 1995-03-02
CA2169840A1 (en) 1995-03-02
CZ42596A3 (en) 1996-06-12
NO960653L (en) 1996-02-19
KR960703570A (en) 1996-08-31
HU9600376D0 (en) 1996-04-29
AU7530594A (en) 1995-03-21
FI960749A0 (en) 1996-02-19
JPH09501682A (en) 1997-02-18
DK95093D0 (en) 1993-08-20
PL313113A1 (en) 1996-06-10
CN1132478A (en) 1996-10-02
LT4043B (en) 1996-09-25
EP0789560A1 (en) 1997-08-20
LT96010A (en) 1996-06-25
HUT74167A (en) 1996-11-28
SK19396A3 (en) 1997-03-05
NO960653D0 (en) 1996-02-19

Similar Documents

Publication Publication Date Title
BR9407306A (en) Pharmaceutical composition for oral administration and process for preparing the same
BR1100850A (en) Compound, process for the preparation of a compound, and pharmaceutical composition
BR9201657A (en) AMINATED AROMATIC DERIVED COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITION
MX9101175A (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
BR9204361A (en) COMPOUND AND PROCESS FOR ITS PREPARATION PHARMACEUTICAL AND INTERMEDIATE FORMULATION
BR9504509A (en) Compound process for its preparation and pharmaceutical formulation
BR9605354A (en) Compound pharmaceutical composition process for compound production and use
FI892640A (en) A process for preparing a pharmaceutical composition comprising a piperidinoalkanol-ibuprofen combination
BR9202522A (en) COMPOUND, PHARMACEUTICAL FORMULATION AND PROCESS TO PREPARE A COMPOUND
BR9505107A (en) Compound pharmaceutical composition process for the preparation of a compound and its use
BR9103036A (en) COMPOUND, PHARMACEUTICAL FORMULATION AND PROCESS FOR THE PREPARATION OF COMPOUND
BR9202325A (en) COMPOUND, PROCESS FOR ITS PREPARATION, PHARMACEUTICAL PREPARATION AND PROCESS FOR ITS PREPARATION
BR9101121A (en) COMPOUND, PROCESS FOR ITS PREPARATION, ITS APPLICATIONS, AND PHARMACEUTICAL PREPARATION
BR9607095A (en) Compound pharmaceutical composition and processes for making and administering a compound
BR9711340A (en) Compound pharmaceutical composition and process for preparing a compound
BR9506106A (en) Process compound for its drug preparation and pharmaceutical composition
BR9402961A (en) Freeze-dried pharmaceutical dosage form and process for preparing the same
BR9206950A (en) Pharmaceutical composition and process for its preparation
BR9303456A (en) COMPOUNDS, PROCESS FOR PREPARATION, DRUGS, PROCESS FOR PREPARATION AND EMPLOYMENT
BR9305161A (en) Compound, pharmaceutical composition and process for preparing the compound
BR9701085A (en) Crystalline vitamin D derivative Process to prepare the same drug Pharmaceutical composition Process to prepare the same and use the derivative
BR9608120A (en) Pharmaceutical composition and process for preparing it
BR9505132A (en) Compound process for the preparation of its use, pharmaceutical composition and process for the production of the same
PT97550A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN, AND A PROSTAGLANDINE
BR9401965A (en) Antiallergic pharmaceutical composition for topical ophthalmic administration and process to produce the same

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal